Comparing 150cm OAGB With 150cm Biliopancreatic Limb RYGB. A Non-inferiority Trial
Recruiting
N/A
Interventional Study
Bariatric Surgery Candidate
Obesity
Obesity, Morbid
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 298 (estimated)
- Sponsor
- Flevoziekenhuis · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to assess the safety and efficiency of OAGB compared to RYGB
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* body-mass index (BMI) of 40 kg/m2 or higher, or 35 kg/m2 or higher with the presence of at least one comorbidity (type 2 diabetes, high blood pressure, obstructive sleep apnoea, dyslipidaemia, osteoarthritis of the hip or knee)
* a positive evaluation by our BMDT
Exclusion Cr…
Contacts